Blood centers prioritize the safety of both the donor and the recipient
advise on evidence and risks
LB has received consultancy fees from Corcept Therapeutics, Gilead, Janssen Pharmaceuticals, Inc., Lyndra Therapeutics, Merck, Novo Nordisk, Salix Pharmaceuticals, and Sanofi
This dietary pattern is low in total carbohydrates
These efforts have led to the development of various GLP-1 receptor agonists, the most recent being semaglutide and tirzepatide, approved for the treatment of type 2 diabetes in 2018 and 2022, respectively
This peptide consists of 44 amino acids, featuring a modified C-terminus that includes the addition of six Lysine (Lys) residues and the removal of one Proline (Pro) residue